Skip to main content
. 2023 Sep 26;149(19):17051–17069. doi: 10.1007/s00432-023-05350-5

Table 3.

Median overall and progression-free survival of histological subtypes

N Median OS (95% CI) (months) N Median PFS (95% CI) (months)
407 214
Angiosarcoma 17 (10, 26) 7.0 (5.0, 15)
Dermatofibrosarcoma protuberans 22 (—, —) 1.0 (—, —)
Fibromyxoid sarcoma 5.0 (—, —)
Fibrosarcoma 24 (23, 115) 22 (18, —)
Leiomyosarcoma 27 (23, 34) 25 (15, 36)
Liposarcoma 32 (24, 54) 18 (12, 36)
Malignant peripheral nerve sheath tumor 20 (11, 70) 9.0 (7.0, —)
Myxofibrosarcoma 56 (24, —) 40 (7.0, —)
Pleomorphic sarcoma 30 (23, 58) 21 (17, —)
Rhabdomyosarcoma 6.0 (3.0, —) 2.5 (2.0, —)
Soft tissue sarcoma 22 (14, 29) 9.0 (6.0, 21)
Spindle cell sarcoma 50 (22, —)
Synovial sarcoma 18 (8.0, —)